Big Pharma isn't dead, but long live small pharma! - Pharmaceutical Executive


  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Big Pharma isn't dead, but long live small pharma!
Comments from our Readers
Return to article
 Posted Jul 17 2009 02:29PM
Good to see people picking up on the fact that much of the innovation in pharma and biotech comes from smaller, specialty companies. Big Pharma seems to be moving further toward in-licensing later stage compounds and leaving discovery and early stage development to the smaller innovators, who can do it more efficiently. There's room for both models, and I believe that a strong small to mid-cap pharma and biotech sector is good for the industry overall, and especially good for big pharma when they need to go shopping for deals. Big Pharma has been building its pipelines through in-licensing and acquisitions from smaller players.
post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.


Click here